Home

Monica A rischio composito amgen clinical trials scrittura Seno servire

Amgen Careers - “I always feel valued for my work and understand how I fit  into the bigger picture,” says Tom Morley, Senior Clinical Trial Manager,  of his experience on our Global
Amgen Careers - “I always feel valued for my work and understand how I fit into the bigger picture,” says Tom Morley, Senior Clinical Trial Manager, of his experience on our Global

A Strategy for Making Clinical Trials More Successful | Amgen
A Strategy for Making Clinical Trials More Successful | Amgen

Cytokinetics | Clinical Trials | ALS | Heart Failure | SMA
Cytokinetics | Clinical Trials | ALS | Heart Failure | SMA

Reimagining patient-centric cancer clinical trials: a multi-stakeholder  international coalition | Nature Medicine
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine

Amgen shares hit after analysts expose buried FDA trial halt | Fierce  Biotech
Amgen shares hit after analysts expose buried FDA trial halt | Fierce Biotech

Clinical Trials | Amgen
Clinical Trials | Amgen

Inside Amgen's Push for Greater Diversity in Clinical Trials | Amgen
Inside Amgen's Push for Greater Diversity in Clinical Trials | Amgen

Amgen taps Syapse to infuse real-world data into its cancer clinical trial  designs | Fierce Biotech
Amgen taps Syapse to infuse real-world data into its cancer clinical trial designs | Fierce Biotech

Clinical Trials | Amgen
Clinical Trials | Amgen

Amgen Psoriatic Arthritis Clinical Trials - Advanced Rheumatology of Houston
Amgen Psoriatic Arthritis Clinical Trials - Advanced Rheumatology of Houston

Amgen scientists' rapid work to challenge the undruggable KRAS G12C  mutation in cancer
Amgen scientists' rapid work to challenge the undruggable KRAS G12C mutation in cancer

Clinical Trials | Amgen
Clinical Trials | Amgen

Biosimilars Clinical Trials | Amgen Biosimilars
Biosimilars Clinical Trials | Amgen Biosimilars

AMGEN, CYTOKINETICS AND SERVIER ANNOUNCE TOPLINE RESULTS FROM GALACTIC-HF,  A PHASE 3 TRIAL OF OMECAMTIV MECARBIL IN PATIENTS WITH HEART FAILURE -  Servier
AMGEN, CYTOKINETICS AND SERVIER ANNOUNCE TOPLINE RESULTS FROM GALACTIC-HF, A PHASE 3 TRIAL OF OMECAMTIV MECARBIL IN PATIENTS WITH HEART FAILURE - Servier

FDA approves Amgen drug for lung cancer with specific mutation
FDA approves Amgen drug for lung cancer with specific mutation

Amgen unveils its KRas inhibitor in human clinical trials
Amgen unveils its KRas inhibitor in human clinical trials

Clinical Trials | Amgen
Clinical Trials | Amgen

Clinical Trials | Amgen
Clinical Trials | Amgen

How Amgen Is Taking An Adaptive Approach To Clinical Trials
How Amgen Is Taking An Adaptive Approach To Clinical Trials

Amgen deploys StudyTeam enrollment software
Amgen deploys StudyTeam enrollment software

Clinical Trials | Amgen
Clinical Trials | Amgen

Amgen unveils its KRas inhibitor in human clinical trials
Amgen unveils its KRas inhibitor in human clinical trials

Another one BiTEs the dust as Amgen pauses enrollment for phase 1  bispecific trial | Fierce Biotech
Another one BiTEs the dust as Amgen pauses enrollment for phase 1 bispecific trial | Fierce Biotech

Clinical Trials | Amgen
Clinical Trials | Amgen